2009 Bio International Convention
About the Convention
If you are still deciding on whether the 2009 BIO International Convention is the right fit for you, imagine your three most pressing business challenges. Are they in any of the following areas...then this year's event is the place to be!
· Achieving Regulatory Approval
· Business Development
· Clinical Research/Clinical Trials
· Devices and Predictive Diagnostics
· Global Biotechnology Issues
· Drug Discovery and Development
· Exciting Science 2009
· Finance
· Food and Agriculture
· Growing the Biotech Workforce
· Industrial and Environmental
· Legal Issues
· Manufacturing of Biologics & Drugs
· Policy
· Public Relations/Investor Relations
· Technology Transfer/Licensing
· Translational Medicine
· Vaccines
The Global Event for Biotechnology
The BIO International Convention is the largest global event for the biotechnology industry and attracts the biggest names in biotech, offers key networking and partnering opportunities, and provides insights and inspiration on the major trends affecting the industry.
The event features keynotes and sessions from key policymakers, scientists, CEOs, and celebrities. Past speakers include President George W. Bush, President Bill Clinton, Michael J. Fox, Her Majesty Queen Noor of Jordan, and General Colin Powell, among many others. The convention also includes hundreds of sessions covering biotech trends, policy issues and technological innovations, and the world's largest biotechnology exhibition - the BIO Exhibition.
In 2007, Tradeshow Week (TSW) named the BIO International Convention as one of the Fastest 50, a list of the fastest-growing trade shows. TSW editorial and research staff Selected the Fastest 50 based on 50 percent total net square footage growth and 50 percent net growth between 2004 and 2006.
BIO
BIO performs many services for members, but none of them is more visible than the BIO International Convention, the largest biotechnology event in the world. The BIO International Convention helps BIO fulfill its mission to help grow the global biotech industry.
Profits from the BIO International Convention are returned to the biotechnology industry by supporting BIO programs and initiatives. BIO works throughout the year to create a policy environment that enables the industry to continue to fulfill its vision of bettering the world through biotechnology innovation.
History and Background
The event dates back to 1987, when the Association of Biotechnology Companies hosted an international conference in Washington, D.C., that exceeded expectations by attracting 155 attendees - the goal had been 100. Some of the session topics would become perennial themes: raising capital in the venture and public markets; FDA, USDA, and EPA regulation; and patenting trends.
Since then, growth has been steady - attendance hit 1,400 in 1993, the year BIO was formed, and more than 22,000 in 2007, with representatives from 68 countries. Media coverage has increased as well, from a smattering of trade-press reporters in the early years to more than 500 reporters in recent years. Growth of the meeting, and BIO overall, has paralleled that of the young, dynamic industry BIO represents.
English
